Procter & Gamble has issued full-year 2027 guidance, new quarterly earnings expectations, and updated details on capital returns including dividends and share buybacks, all released alongside its latest annual results. The company's share price stands at $146.44, with a year-to-date return of 3.28% and a one-year total shareholder return of negative 2.73%. A popular valuation narrative pegs fair value at $107.52, implying the stock is 36.2% overvalued, while a separate discounted cash flow model suggests a fair value of $201.56, indicating the stock is undervalued.
Procter & Gamble CompanyIssued 2027 guidance and capital return details alongside annual results, with mixed valuation signals.
